Dimed S.A. Distribuidora de Medicamentos Stock

Equities

PNVL3

BRPNVLACNOR9

Drug Retailers

Market Closed - Sao Paulo 04:00:00 2024-04-18 pm EDT 5-day change 1st Jan Change
11.14 BRL -6.49% Intraday chart for Dimed S.A. Distribuidora de Medicamentos -7.63% -16.62%
Sales 2024 * 5.08B 967M Sales 2025 * 5.76B 1.1B Capitalization 1.66B 316M
Net income 2024 * 173M 32.92M Net income 2025 * 243M 46.25M EV / Sales 2024 * 0.39 x
Net Debt 2024 * 311M 59.19M Net Debt 2025 * 190M 36.07M EV / Sales 2025 * 0.32 x
P/E ratio 2024 *
9.69 x
P/E ratio 2025 *
5.28 x
Employees 10,284
Yield 2024 *
4.13%
Yield 2025 *
5.39%
Free-Float 55.61%
More Fundamentals * Assessed data
Dynamic Chart
Dimed S.A. Distribuidora de Medicamentos Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Dimed S.A. Distribuidora de Medicamentos Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Dimed S.A. Distribuidora de Medicamentos Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Dimed S.A. Distribuidora de Medicamentos Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Dimed S.A. Distribuidora De Medicamentos Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022 CI
Dimed S.A. Distribuidora de Medicamentos Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Dimed S.A. Distribuidora de Medicamentos Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
Dimed S.A. Distribuidora de Medicamentos Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Dimed S.A. Distribuidora de Medicamentos's Equity Buyback announced on August 13, 2020, has expired with 1,700,000 shares, representing 1.19% for BRL 36.10 million. CI
Dimed S.A. Distribuidora de Medicamentos Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Dimed S.A. Distribuidora de Medicamentos Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Dimed S.A. Distribuidora de Medicamentos Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Tranche Update on Dimed S.A. Distribuidora de Medicamentos's Equity Buyback Plan announced on August 13, 2020. CI
Dimed S.A. Distribuidora de Medicamentos Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Dimed S.A. Distribuidora de Medicamentos's Equity Buyback announced on August 13, 2020, has expired. CI
More news
1 day-6.49%
1 week-7.63%
Current month-7.86%
1 month-7.09%
3 months-9.14%
6 months+3.82%
Current year-16.62%
More quotes
1 week
11.02
Extreme 11.02
12.00
1 month
11.02
Extreme 11.02
12.96
Current year
10.94
Extreme 10.94
13.36
1 year
9.65
Extreme 9.65
13.91
3 years
8.82
Extreme 8.82
21.74
5 years
8.82
Extreme 8.82
34.46
10 years
4.56
Extreme 4.5633
34.46
More quotes
Managers TitleAgeSince
Chief Executive Officer 51 -
Director of Finance/CFO 46 09-12-31
Chairman 78 67-02-28
Members of the board TitleAgeSince
Chairman 78 67-02-28
Director/Board Member 69 08-04-27
Director/Board Member 51 20-07-16
More insiders
Date Price Change Volume
24-04-18 11.14 -0.54% 191,800
24-04-17 11.2 -0.53% 367,100
24-04-16 11.26 -2.09% 442,300
24-04-15 11.5 -3.28% 320,400
24-04-12 11.89 -1.41% 271,000

Delayed Quote Sao Paulo, April 18, 2024 at 04:00 pm EDT

More quotes
Dimed SA Distribuidora de Medicamentos, formerly Panvel SA Drogarias e Farmacias, is a Brazil-based company principally engaged in the sale of drugs. The Company, along with its subsidiaries, sells, distributes, imports, exports and produces a variety of products, including drugs, perfumes, cosmetics, dermo-cosmetics, personal care products, dietary supplements, and fitness, orthopedic and physiotherapy accessories. It organizes its business into two main segments: Medicine and Perfumery. The Company provides retail and wholesale distribution. The Company owns distribution centers in Brazilian states of Rio Grande do Sul, Santa Catarina, Parana, Goias and Espirito Santo, as well as over 280 stores in states of Rio Grande do Sul, Santa Catarina and Parana.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
11.2 BRL
Average target price
17.38 BRL
Spread / Average Target
+55.13%
Consensus

Quarterly revenue - Rate of surprise